Fact Based List:
Top U.S. Life Science R&D Expenditures for Q1-Q3 2012
Submitted by Anonymous on Thu, 12/20/2012 - 14:20
- Pfizer - $5,734
- Merck & Co. - $5,945
- Johnson & Johnson - $5,334
- Lilly (Eli) & Co. - $3,815
- Abbott Laboratories - $3,181
- Bristol-Myers Squibb Co. - $2,822
- Amgen - $2,411
- Celgene - $1,251
- Medtronic (estimated) - $1,167
- Monsanto - $1,166
Notes: In millions
Source: Battelle/R&D Magazine
Source URL: http://www.battelle.org/docs/default-document-library/2013-R...
List Ratings: |
Lists You Might Also Be Interested In
- 5 Blockchain Healthcare Startups
- Arlen Myers, MD: 10 Misconceptions That Hold Back Healthcare Innovation
- 18th Annual Webby Awards: Mobile Health Application Honorees
- Toni Brown and Bill McClain: 6 Tips to Make Sure Your Defined Contribution Plan is Successful
- 4 Key Distribution Channels For mHealth Apps Within The Near Future
Login or register to post comments